跳至主要内容
临床试验/IRCT20210513051277N1
IRCT20210513051277N1
尚未招募
3 期

The effect of probiotic supplementation on cognitive, inflammation and oxidative stress in adults with Alzheimer disease: A randomized, double blind, placebo-controlled trial

Tehran University of Medical Sciences0 个研究点目标入组 30 人待定

概览

阶段
3 期
干预措施
未指定
疾病 / 适应症
未指定
发起方
Tehran University of Medical Sciences
入组人数
30
状态
尚未招募
最后更新
4年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
4年前
研究类型
Interventional
性别
All

研究者

入排标准

入选标准

  • Age 80\-50 years
  • Resident of Tehran
  • Diagnosis of Alzheimer's disease according to NINCDS\-ARDA criteria maximum in the last 2 years
  • BMI\=18/5\-30 Kg/m2
  • Use of acetylcholinesterase inhibitors (AchEIs) and N\-methyl dispartate (NMDA) receptor antagonists
  • caregivers understands the objectives of the study and agrees to follow the necessary rules throughout the study

排除标准

  • Having frontotemporal dementia, Levy Buddy dementia, Parkinson's disease dementia and any type of severe dementia
  • Take antibiotics at least three months before enrollment
  • Smoking (at least 5 cigarettes a day for the past 6 months) and other tobacco (pipe and hookah at least once a month
  • Any drug addiction
  • Follow a specific diet for three months before the study
  • People who participated in another study less than two months ago.
  • Take any amount of supplements or foods fortified with fins or probiotics during the last 3 months
  • History of serious kidney, liver, intestinal, endocrine diseases, cardiovascular, gastrointestinal, pulmonary, blood and metabolic diseases, thyroid, rheumatoid arthritis and lupus
  • History of major gastrointestinal surgeries including gastrectomy, bowel restriction, etc.

结局指标

主要结局

未指定

相似试验